“All I heard is this will be his first external meeting with the stakeholders outside of FDA. This is where Dr. Liau is there and Dr. Liau is the PI of our DcVaxL. Any significance to his visit to UCLA?? Must be I guess. Otherwise there are hundreds of places to visit on the earth, why going there? He is a cancer doc by degree and LP worked for him in the past. FDA is looking for a parallel therapy to CAR-T to treat solid cancers and L and D fit perfectly there, in fact, like flipper teaches us much better than that. Must be something I bet.”
Speaking of UCLA….in case anyone missed this announcement:
UCLA’s Antoni Ribas named American Association for Cancer Research President-Elect
News 
Market Data 
Discover 
AI
